Rocket


News + Filings
Transactions





Fink Jeffrey Arvin

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
05/10/2023Lipocine Inc.LPCNGrantCommon Stock (Right to Buy)30k$0.27$8k 05/10/2023
06/08/2022Lipocine Inc.LPCNGrantCommon Stock (Right to Buy)22k$0.92$20.2k 06/08/2022
06/09/2021Lipocine Inc.LPCNGrantStock Option (Right to Buy)22k$1.26$27.7k 06/09/2021
12/16/2020Lipocine Inc.LPCNExerciseRestricted Stock Unit5.6k$0.00$0 12/16/2020
06/10/2020Lipocine Inc.LPCNGrantStock Option (Right to Buy)22k$0.96$21.2k 06/10/2020
06/12/2019Lipocine Inc.LPCNGrantStock Option (Right to Buy)10k$1.68$16.8k 06/12/2019
06/27/2018Lipocine Inc.LPCNGrantStock Option (Right to Buy)20k$1.33$26.6k 06/27/2018
12/29/2017Lipocine Inc.LPCNExerciseRestricted Stock Unit1.9k$0.00$0 12/29/2017
12/29/2017Lipocine Inc.LPCNSaleCommon stock938$3.47$3.3k 12/29/2017
01/26/2017Lipocine Inc.LPCNGrantRestricted Stock Unit7.5k$0.00$0 01/26/2017
06/14/2016Lipocine Inc.LPCNGrantStock Option (Right to Buy)10k$8.02$80.2k 06/14/2016

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy